Vaknin-Dembinsky A, Brill L, Orpaz N, Abramsky O and Karussis D. Preferential increase of B-cell activating factor in the cerebrospinal fluid of neuromyelitis optica in a white population. Mult Scler 2010; [ePub ahead of print].
2.
ShimizuJHatanakaYHasegawaM. IFNβ-1b may severely exacerbate Japanese optic-spinal MS in neuromyelitis optica spectrum. Neurology2010; 75: 1423–1427.
3.
PalaceJLeiteMINairneAVincentA. Interferon beta treatment in neuromyelitis optica: increase in relapses and aquaporin 4 antibody titers. Arch Neurol2010; 67: 1016–1017.
4.
SpecialeLSaresellaMCaputoD. Serum auto antibodies presence in multiple sclerosis patients treated with beta-interferon 1a and 1b. J Neurovirol2000; 6: S57–S61.
5.
GroomJKalledSLCutlerAH. Association of BAFF/BLyS overexpression and altered B cell differentiation with Sjogren’s syndrome. J Clin Invest2002; 109: 59–68.
6.
FarinaCAloisiFMeinlE. Astrocytes are active players in cerebral innate immunity. Trends Immunol2007; 28: 138–145.
